logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Pharmaceutical
Filter

Pharmaceutical

Categories

Sectors

Locations

Exchange

Grid Therapeutics Closes A Round from Longview Intl. of Singapore

Sep 14, 2017

Life Science

Redhill Biopharma Ltd NASDAQ:RDHL Pharmaceutical, Biotechnology,医药,生物科技

RedHill Biopharma Initiates Promotion of Esomeprazole Strontium Delayed-Release Capsules 49.3 mg in the U.S.

Sep 14, 2017

Life Science

Rocket to merge with Inotek to bag Nasdaq listing, plots gene therapy trials

Sep 14, 2017

Life Science

Resverlogix Corp TSX:RVX Pharmaceutical, Biotechnology, 医药,生物科技

Resverlogix Announces Filing of Quarterly Financial Statements and Management’s Discussion & Analysis

Sep 13, 2017

Life Science

Zai Lab Plans $90 Million IPO at $800 Million Valuation

Sep 13, 2017

Life Science

DelMar Pharmaceuticals Inc NASDAQ:DMPI

DelMar Pharmaceuticals Initiates Phase 2 Clinical Trial in Newly Diagnosed MGMT-unmethylated Glioblastoma Multiforme

Sep 11, 2017

Life Science

Fosun In-Licenses Female Sexual Desire Disorder Drug in $106 Million Deal

Sep 11, 2017

Life Science

Suzhou’s Innovent Strikes $457 Million Deal with CAS for Immuno-Oncology Candidate

Sep 8, 2017

Life Science

WuXi NextCODE, a Genomics CRO, Closes $240 Million Series B Round

Sep 7, 2017

Life Science

DelMar Pharmaceuticals Inc NASDAQ:DMPI

DelMar Pharmaceuticals to Present at the 19th Annual Rodman & Renshaw Global Investment Conference on September 10-12, 2017

Sep 6, 2017

Life Science

Wuxi Fortune Partners with Andarix to Develop Radiotherapeutic in China

Sep 6, 2017

Life Science

Sisram, a Fosun Pharma Device Company, Staging a $200 Million Hong Kong IPO

Sep 6, 2017

Life Science

OrbiMed Raises $551 Million for Third Asia Healthcare Fund

Sep 6, 2017

Life Science

Resverlogix Corp TSX:RVX Pharmaceutical, Biotechnology, 医药,生物科技

Resverlogix Closes Extension of Maturity Date of Loan and Announces Private Placement

Sep 5, 2017

Life Science

Yisheng Biopharma Reports “Breakthrough” Efficacy of Lead Immuno-Oncology Drug

Sep 1, 2017

Life Science

Why Tencent is plowing tens of millions into American health tech start-ups

Aug 31, 2017

Life Science

Fosun Pharma Acquires 65% Stake In SinoMedCare for $40 Million

Aug 31, 2017

Life Science

iCAD Gains CFDA Approval to Market Brachytherapy Device in China

Aug 31, 2017

Life Science

  • ‹‹ Previous
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada